Reddit stock wobbles after the bell as RDDT traders brace for this week’s earnings

Reddit stock wobbles after the bell as RDDT traders brace for this week’s earnings

Reddit shares closed down 1.7% at $177.15 Monday, then rose 0.8% after hours as investors positioned ahead of Thursday’s earnings report. Options markets signaled expectations for a sharp move, with 30-day implied volatility at 82%. Evercore ISI maintained an “Outperform” rating and a $320 price target. Reddit will release results after the bell Thursday, followed by a conference call at 4:30 p.m. ET.
Applied Digital Corporation (APLD) stock ticks up in late trade as insider sale filings land

Applied Digital Corporation (APLD) stock ticks up in late trade as insider sale filings land

Applied Digital shares rose 2.7% to $34.80 in late Monday trading, with nearly 23 million shares changing hands. Director Chuck Hastings sold 45,987 shares at $38.57 each on Jan. 29 and filed to sell up to 100,000 shares. The company began construction on its 430-megawatt Delta Forge 1 “AI Factory” campus, targeting mid-2027 operations. Vanguard disclosed an 8.65% stake as of Dec. 31.
Carnival stock jumps 8% after the bell as oil sinks and Wave season chatter lifts cruise shares

Carnival stock jumps 8% after the bell as oil sinks and Wave season chatter lifts cruise shares

Carnival shares surged 8.1% to $32.45 Monday, tracking gains in travel stocks after oil prices plunged more than $3 a barrel on easing Iran-U.S. tensions. Trading volume topped 30 million shares. Early Wave season bookings and pricing are running ahead of last year’s levels. Carnival’s next earnings report is scheduled for March 20.
RTX stock price hovers near $201 after BofA boosts target; Raytheon posts fresh defense updates

RTX stock price hovers near $201 after BofA boosts target; Raytheon posts fresh defense updates

RTX shares edged up 0.1% to $201.09 in after-hours trading Monday after Raytheon announced new DARPA contracts and a successful U.S. Army missile test. BofA Securities raised its price target to $230, citing strong demand. Supply-chain issues continue to affect aerospace deliveries and repairs. Investors remain alert to possible U.S. policy changes on defense contractor payouts.
AbbVie stock gains ahead of earnings; ABBV investors brace for guidance and a $1.3 billion expense

AbbVie stock gains ahead of earnings; ABBV investors brace for guidance and a $1.3 billion expense

New York, February 2, 2026, 16:10 (EST) — After-hours trading AbbVie shares climbed $2.69, or 1.2%, on Monday, settling at $225.70 after hitting a session high of $229.80. AbbVie is set to release full-year and fourth-quarter earnings on Wednesday. Investors will be watching to see if its newer products can step up as Humira’s sales decline amid growing competition from generics. This is crucial now since the stock can’t afford to wander. Investors demand the numbers first, then the outlook — and both need to meet the high expectations already established in large-cap healthcare. Monday’s market moved more quietly, with
Abbott (ABT) stock price steadies after Barclays trims target; Exact Sciences vote is next key date

Abbott (ABT) stock price steadies after Barclays trims target; Exact Sciences vote is next key date

Abbott Laboratories shares edged up 0.1% to $109.43 after Barclays cut its price target to $142 but kept an Overweight rating. Nutrition sales fell 8.9% last quarter, and diagnostics dropped 2.5%. Exact Sciences shareholders will vote February 20 on Abbott’s planned $23 billion takeover. The deal is expected to close in the second quarter of 2026.
Carvana stock ticks higher after-hours as traders size up short report, earnings ahead

Carvana stock ticks higher after-hours as traders size up short report, earnings ahead

Carvana shares rose 1.7% in after-hours trading Monday, closing at $407.83 after a volatile session. The move follows allegations from Gotham City Research that Carvana inflated profits through undisclosed related-party transactions, which the company denies. Analysts at JPMorgan and BTIG questioned the short seller’s claims. Investors await Carvana’s earnings report and call on Feb. 18.

Stock Market Today

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

Pfizer stock price rises into weekend as FDA priority review, TrumpRx discounts grab focus

7 February 2026
New York, February 7, 2026, 05:48 EST — Market closed Pfizer Inc (PFE) shares ended Friday up 2.8% at $27.22, after trading between $26.52 and $27.37. About 50.7 million shares changed hands. (Yahoo Finance) The stock’s late-week lift comes with a key regulatory clock running: the FDA granted priority review for Pfizer’s supplemental filing to broaden use of its hemophilia drug Hympavzi, with a target decision deadline in the second quarter. Priority review shortens the agency’s standard review timeline by four months. “There is a significant medical need for younger patients with hemophilia and for those who have developed inhibitors,”
Go toTop